In the latest installment of CURE's "Text a Survivor" series, Brad Moore answers some of the most common questions people have about living with and beyond a colorectal cancer diagnosis.
|Videos|June 5, 2016
Nathalie Le Vasseur on a Review of Optimal Weight Control Strategies
Author(s)Nathalie Le Vasseur
This research was presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of over 30,000 oncology professionals in Chicago.
Advertisement
Nathalie Le Vasseur, from the University of Ottawa, discusses a review of optimal weight control strategies in patients with cancer. This research was presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of over 30,000 oncology professionals in Chicago.
Advertisement
Related to this article
Researchers are studying whether combining CAR-T cell therapy with targeted drugs could help children with high-risk leukemia, including infants whose cancer may be more likely to return after treatment.
Deborah A. McDowell of OAW explains how patients can prepare for hair loss before chemotherapy starts.
Progression-free survival reached 14.3 months with Enhertu versus 8.3 months with chemotherapy plus Keytruda in HER2-mutant lung cancer.
Dr. Dina Khalaf breaks down three clinical trials testing oral and targeted regimens for acute myeloid leukemia and myelodysplastic syndrome.
Advertisement
Advertisement
Trending on CURE
1
Finding the Words: How to Talk to Someone With Cancer
2
Getting Ready to Swim in a Sea of Pink
3
FDA Approves Bravnetsa, an Equivalent to Lutathera, for GEP-NETs
4
Cancer Research Is Looking Beyond the Tumor to Better Understand the Whole Patient
5